Beta Bionics Chief Commercial Officer Hopman Mark sold 5,327 shares at $19.11 each on September 2, 2026. The transaction left Hopman Mark holding 124,027 Beta Bionics shares, giving investors the stated post-transaction ownership figure for the executive in the company.
Key Highlights
- The transaction took place on September 2, 2026.
- Hopman Mark serves as Beta Bionics' Chief Commercial Officer.
- Hopman Mark owned 124,027 shares after the transaction.
Beta Bionics, Inc. (NASDAQ: BBNX) Chief Commercial Officer Hopman Mark sold 5,327 shares at $19.11 per share. The transaction occurred on September 2, 2026, and the reported post-transaction ownership was 124,027 shares.
Beta Bionics Officer Sale Details
Hopman Mark’s role at Beta Bionics is Chief Commercial Officer. The reported date was September 2, 2026. Beta Bionics, Inc. is the company named in connection with the transaction, and BBNX is its listed symbol. The sale price was stated on a per-share basis. The reported quantity refers to shares sold by Hopman Mark.
124,027 Shares Owned After Transaction
Following the transaction, Hopman Mark owned 124,027 Beta Bionics shares. That figure is the stated ownership position after the sale. The reported post-transaction holding identifies the number of Beta Bionics shares owned by Hopman Mark after the September 2 transaction. The transaction information connects the 124,027 shares with the company’s Chief Commercial Officer.
FAQs
Q: Who sold Beta Bionics shares on September 2, 2026?
A: Hopman Mark, Beta Bionics’ Chief Commercial Officer, sold 5,327 shares on September 2, 2026. The reported transaction price was $19.11 per share.
Q: How many Beta Bionics shares did Hopman Mark own after the sale?
A: Following the reported transaction, Hopman Mark’s post-transaction ownership was 124,027 Beta Bionics shares. The filing identifies this figure as his ownership position after the sale.
Q: What was the price of Hopman Mark’s BBNX share sale?
A: The Beta Bionics share sale was priced at $19.11 per share. The transaction covered 5,327 shares sold by Chief Commercial Officer Hopman Mark.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.